Wengelsdorf, Germany

Matthias Hoffmann


Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2006-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Matthias Hoffmann in Neuropsychiatric Treatments

Introduction

Matthias Hoffmann is a notable inventor based in Wengelsdorf, Germany. He has made significant contributions to the field of neuropsychiatric treatments, holding a total of four patents. His work primarily focuses on the therapeutic applications of dipeptidyl peptidase IV inhibitors.

Latest Patents

Hoffmann's latest patents include innovative methods for treating schizophrenia and depression. One of his key inventions involves a method for therapeutically treating animals, including humans, for various psychosomatic, depressive, and neuropsychiatric diseases. This includes conditions such as anxiety, depression, insomnia, schizophrenia, epilepsy, spasm, and chronic pain. The administration of a suitable DP IV inhibitor leads to a reduction in the activity of the enzyme dipeptidyl peptidase, which in turn reduces the degradation of neuropeptide Y in the brain. This enhanced stability of neuropeptide Y results in prolonged activity, facilitating various neurological effects, including antidepressive and anxiolytic properties.

Another significant patent focuses on the treatment of anxiety using similar methods. The therapeutic approach aims to improve the stability and activity of neuropeptide Y, thereby providing relief from anxiety and other related conditions.

Career Highlights

Throughout his career, Matthias Hoffmann has worked with various companies, including Probiodrug AG. His innovative research has positioned him as a key figure in the development of new treatments for neuropsychiatric disorders.

Collaborations

Hoffmann has collaborated with notable professionals in his field, including Hans-Ulrich Demuth and Ants Kask. These collaborations have further enhanced the impact of his research and inventions.

Conclusion

Matthias Hoffmann's contributions to the field of neuropsychiatric treatments through his patents demonstrate his commitment to advancing medical science. His innovative approaches have the potential to significantly improve the quality of life for individuals suffering from various mental health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…